Travelers Companies reported strong second-quarter 2025 earnings with revenue of $12.12 billion, a 7.4% year-over-year increase, and net income of $1.51 billion. The company posted an earnings per share (EPS) of $6.53 and a core EPS of $6.51, significantly surpassing estimates. The combined ratio was 90.3%, with an underlying combined ratio of 84.7%, driven by lower catastrophe losses and higher underwriting gains. Abbott Laboratories reported Q2 revenue of $11.14 billion, slightly above estimates, with adjusted EPS of $1.26 and organic sales growth of 6.9%, slightly below expectations. The company provided a Q3 adjusted EPS forecast of $1.28 to $1.32 and a full-year adjusted EPS outlook of $5.10 to $5.20. Thermo Fisher Scientific posted Q2 revenue of $10.855 billion and adjusted EPS of $5.36, beating estimates, with GAAP EPS of $4.28. The company expects full-year adjusted EPS between $22.22 and $22.84. Hilton Worldwide reported Q2 revenue of $3.14 billion, a 3.3% increase year-over-year, with adjusted EPS of $2.20 and net income of $442 million. Despite a 0.5% decline in system-wide comparable RevPAR, Hilton maintains a strong development pipeline and provided a full-year adjusted EPS guidance of $7.83 to $8.00. Honeywell delivered Q2 sales of $10.4 billion, up 8%, with adjusted EPS of $2.75, exceeding estimates, and raised its 2025 adjusted EPS guidance to $10.45–$10.65, citing sustained demand for aerospace parts and services. L3Harris Technologies reported Q2 revenue of $5.40 billion and adjusted EPS of $2.78, beating estimates, with a 2025 adjusted EPS outlook of $10.40–$10.60. Aon posted Q2 revenue of $4.16 billion, in line with estimates, with adjusted EPS of $3.49 and organic revenue growth of 6%. AutoNation reported Q2 revenue of $7.0 billion and adjusted EPS of $5.46, both exceeding expectations, with adjusted net income of $209.2 million. These results reflect robust performances across insurance, healthcare, industrial, hospitality, and automotive sectors in the second quarter of 2025.